VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $269,507 | -7.9% | 16,626 | -5.4% | 0.00% | – |
Q1 2023 | $292,607 | +103.6% | 17,574 | +14.9% | 0.00% | – |
Q4 2022 | $143,735 | +219.4% | 15,291 | -6.7% | 0.00% | – |
Q3 2022 | $45,000 | -15.1% | 16,382 | -10.8% | 0.00% | – |
Q2 2022 | $53,000 | -72.8% | 18,356 | -40.9% | 0.00% | – |
Q3 2021 | $195,000 | +9.6% | 31,050 | +4.8% | 0.00% | – |
Q2 2021 | $178,000 | -2.7% | 29,633 | +2.3% | 0.00% | – |
Q1 2021 | $183,000 | +60.5% | 28,956 | +42.7% | 0.00% | – |
Q4 2020 | $114,000 | -30.9% | 20,297 | -28.4% | 0.00% | – |
Q3 2020 | $165,000 | -27.9% | 28,330 | -11.0% | 0.00% | – |
Q2 2020 | $229,000 | +23.1% | 31,822 | -19.7% | 0.00% | – |
Q1 2020 | $186,000 | -42.2% | 39,648 | -1.1% | 0.00% | – |
Q4 2019 | $322,000 | +22.4% | 40,094 | +4.9% | 0.00% | – |
Q3 2019 | $263,000 | -18.1% | 38,209 | -1.2% | 0.00% | – |
Q2 2019 | $321,000 | -13.2% | 38,687 | +3.8% | 0.00% | -100.0% |
Q1 2019 | $370,000 | +118.9% | 37,260 | +68.3% | 0.00% | – |
Q4 2018 | $169,000 | – | 22,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |